Xcout Intel
Diagnos Inc.
DIAGNOS Inc. is a technology firm that delivers software-based services across a broad international footprint, encompassing Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. A significant portion of its operations focuses on healthcare, where it provides Computer Assisted Retina Analysis (CARA). This advanced web-based platform is designed to support medical professionals in the early detection of diabetic retinopathy. It also empowers eye care specialists by enabling clear visualization of both standard retinal features and any pathological changes. Beyond its healthcare offerings, DIAGNOS Inc. extends its expertise through consulting services, specializing in the fields of data analytics and artificial intelligence (AI). Established in 1998, the company maintains its corporate headquarters in Brossard, Canada.
Subscribe to see Diagnos Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Diagnos Inc. at a glance
Diagnos Inc. is a healthtech company headquartered in Brossard, Canada. It is publicly listed (ADK) with a market capitalisation of $17.4M. Xcout tracks 15 named people at Diagnos Inc., including Marc-Andre Massue (Chief Financial Officer).
Diagnos Inc. leadership
- Marc-Andre MassueChief Financial Officer
- Andre LarentePrésident - Directeur
- Andre LarenteExecutive Officer
- Marc-Andre MassueExecutive Officer
- Philippe CouillardExecutive Officer
- Yves-Stephane CoutureExecutive Officer
9 more named people on record for Diagnos Inc., with roles, board committees and tenure — see the full roster →
Diagnos Inc. competitors
A few of Diagnos Inc.'s closest competitors — see the full list of competitors and alternatives →
Vara provides CE-marked artificial intelligence software designed for European breast cancer screening and diagnostics. The company's platform assists radiologists and screening programs with case triage, automated reporting, and lesion detection to improve early cancer detection and workflow efficiency.
Optain Health, Inc. is a healthcare technology company founded in 2023 and headquartered in New York City. The company utilizes artificial intelligence, robotic retinal imaging, and teleophthalmology to provide non-invasive screening and early detection of systemic and chronic diseases.
Beijing Airdoc Technology Co., Ltd. provides artificial intelligence (AI) empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally. The company offers a software as a medical device (SaMD) product, Airdoc-AIFUNDUS, which is an AI-assisted diagnosis of retinal detection product that is available in three versions comprising version 1.0 for the diagnosis of diabetic retinopathy, version 2.0 that address various fundus diseases, and version 3.0 for the diagnosis of pathological myopia and retinal detachment. It also provides the AI-FUNDUSCAMERA-P, a portable automatic and self-service fundus camera that can complete the retinal image capture without an operator; AI-FUNDUSCAMERA-D, a fully automatic and self-service desktop fundus camera; and AI-FUNDUSCAMERA-M, a multimodal health scanner that integrates biosensors that supports a number of health detection functions. In addition, the company offers health risk assessment solutions to detect risk indicators, such as retinal abnormalities and vascular diseases, vitreous abnormalities, retinal tumors, optic nerve pathologies, macular diseases, congenital anomalies of the retina, cardiovascular disease, and anemia. In addition, it develops SaMD products for glaucoma and cataracts detection; an AI-driven integrated myopia intervention solutions, including the PBM LED myopia therapy device; and an AI-based visual training product for the treatment of strabismus and amblyopia. The company was formerly known as Beijing Tulip Partner Technology Co., Ltd. and changed its name to Beijing Airdoc Technology Co., Ltd. in December 2020. Beijing Airdoc Technology Co., Ltd. was incorporated in 2015 and is headquartered in Beijing, the People’s Republic of China.
Covera Health is a technology and healthcare insights company headquartered in the United States that supports providers, health plans, and employers throughout the diagnostic and care ecosystem.
Based in Toronto, Canada, Firefly Neuroscience, Inc. is a medical technology and artificial intelligence firm specializing in developing neuroscientific solutions. The company's primary goal is to enhance patient outcomes for individuals affected by mental illnesses and neurological disorders. Its flagship product, Brain Network Analytics, is a sophisticated software platform engineered to aid in the diagnosis and treatment of a diverse range of cognitive and psychiatric conditions. These conditions encompass, but are not limited to, depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. Firefly Neuroscience, Inc. caters to both pharmaceutical companies and medical practitioners.
Get Diagnos Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Diagnos Inc. in Xcout Intel
- 15 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access